WASHINGTON - Healthcare products conglomerate Johnson Johnson is buying privately-held Aragon Pharmaceuticals in near $1 billion deal to gain... ...
http://www.calcuttanews.net/index.php/sid/215254611/scat/3a8a80d6f705f8cc/PRNewswire/ -- NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=48548&title=NGM-Biopharmaceuticals-and-MedImmune-AstraZenecas-Biologics-Arm-Announce-Agreement-to-Discover-and-Develop-Therapies-for-Diabetes-and-ObesityPR Newswire SUNNYVALE, Calif., June 16, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today announced the results of... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=48539&title=Updated-Results-of-Two-Phase-2-Ibrutinib-Studies-in-Patients-with-Mantle-Cell-Lymphoma-or-Diffuse-Large-Bcell-LymphomaData presented at the European Hematology Association (EHA) Annual Congress PR Newswire RARITAN, N.J., June 16, 2013 /PRNewswire/ --Janssen... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=48538&title=Ibrutinib-Phase-2-Data-Analyses-Show-Efficacy-with-Ibrutinib-Monotherapy-in-Patients-with-Relapsed-or-Refractory-Mantle-Cell-or-Diffuse-Large-Bcell-Lymphoma/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ... ...
http://in.advfn.com/p.php?pid=nmona&article=57967084